Presentations and Publications

2018 CommNETs Publications

Click here for: Chan D.L., Moody L., Segelov E., Metz D., Strosberg J., Pavlakis N., Singh S. (2018). “Follow-up for resected gastroenteropancreatic neuroendocrine tumours (GEP-NETs): A practice survey of the Commonwealth Neuroendocrine collaboration (CommNETs) and the North American Neuroendocrine Tumor Society (NANETS).” Neuroendocrinology (accepted for publication), doi:10.1159/000488394.

Click here for: Singh S., Moody L., Chan D.L. Metz D., Strosberg J., Asmis T., Bailey D., Bergsland E., Brendtro K., Carroll R., Cleary S., Kim M., Kong G., Law C., Lawrence B., McEwan S., McGregor C., Michael M., Pasieka J., Pavlakis N., Pommier R., Soulen M., Wyld D., Segelov E. (2018) “Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumours.” JAMA Oncology, doi: doi:10.1001/jamaoncol.2018.2428.

Click here for: Singh S, Chan DL, Moody L, Liu N, Fischer HD, Austin PC, Segelov E. 2018. Recurrence in Resected Gastroenteropancreatic Neuroendocrine Tumors. JAMA Oncology. 4:583-585. Impact factor 16.

2017 CommNETs Publications

Click here for: Segelov, E., Chan, D., Lawrence, B., Pavlakis, N., Kennecke, H. F., Jackson, C., et al. (2017). Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration., 3(4), 380–388.

2017 CommNETs members NET publications

Click here for: “Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance.” Theranostics 7(5): 1149-1158.

Click here for: Chan, D. L. H., et al. (2017). “Prognostic and predictive biomarkers in neuroendocrine tumours.” Crit Rev Oncol Hematol 113: 268-282.

2018 Presentations

VCCC Survivorship Conference February 8th – 9th | Melbourne, VIC, Australia

Poster Presented by Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) PRRT Working Group

The challenges of designing and implementing a structured, international multicentre audit on quality of life (QOL) and markers of response in patients with neuroendocrine neoplasms (NEN) treated with peptide receptor radionuclide therapy (PRRT). Poster presented: Click here

Past Presentations

To view all past CommNETs presentations, and NETs presentations by CommNETs members please click here